Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Langer

Showing results (361-370 of 596) with videos related to

Pageof 60
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 1, 2010
Randomized phase II trial of cisplatin, etoposide, and radiation followed by gemcitabine alone or by combined gemcitabine and docetaxel in stage III A/B unresectable non-small cell lung cancerBenjamin Movsas, Corey J Langer, Helen J Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysisC J Langer, J C Leighton, R L Comis, et al.
Clinical Lung Cancer|December 10, 2003
Temozolomide in non-small-cell lung cancer: preliminary results of a phase II trial in previously treated patientsChristian S Adonizio, James S Babb, Christine Maiale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599Suresh S Ramalingam, Suzanne E Dahlberg, Corey J Langer, et al.
Frontiers in Surgery|July 9, 2026
Contemporary indications and outcomes of open surgical cerebral aneurysm management in the endovascular eraJonathan Rychen, Christian Ferreira, Marcio Y Ferreira, et al.
AJNR. American Journal of Neuroradiology|October 13, 2006
Treatment of cerebral aneurysms with hydrogel-coated platinum coils (HydroCoil): early single-center experienceA Berenstein, J K Song, Y Niimi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2012
Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancerM A Socinski, C J Langer, I Okamoto, et al.
The Laryngoscope|September 2, 2006
Laryngeal cancer in the United States: changes in demographics, patterns of care, and survivalHenry T Hoffman, Kimberly Porter, Lucy H Karnell, et al.
Mbio|May 25, 2017
Mutations That Alter the Bacterial Cell Envelope Increase Lipid ProductionKimberly C Lemmer, Weiping Zhang, Samantha J Langer, et al.
Journal of Neurological Surgery. Part A, Central European Neurosurgery|December 8, 2020
Brain Arteriovenous Malformations: Impact of Neurologic Status, Bleeding, and Type of Treatment on Final OutcomeSara García-Duque, Roberto García-Leal, Begoña Iza-Vallejo, et al.
Pageof 60

Showing results (361-370 of 596) with videos related to

Sort By:
Pageof 60
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 1, 2010
Randomized phase II trial of cisplatin, etoposide, and radiation followed by gemcitabine alone or by combined gemcitabine and docetaxel in stage III A/B unresectable non-small cell lung cancerBenjamin Movsas, Corey J Langer, Helen J Ross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysisC J Langer, J C Leighton, R L Comis, et al.
Clinical Lung Cancer|December 10, 2003
Temozolomide in non-small-cell lung cancer: preliminary results of a phase II trial in previously treated patientsChristian S Adonizio, James S Babb, Christine Maiale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599Suresh S Ramalingam, Suzanne E Dahlberg, Corey J Langer, et al.
Frontiers in Surgery|July 9, 2026
Contemporary indications and outcomes of open surgical cerebral aneurysm management in the endovascular eraJonathan Rychen, Christian Ferreira, Marcio Y Ferreira, et al.
AJNR. American Journal of Neuroradiology|October 13, 2006
Treatment of cerebral aneurysms with hydrogel-coated platinum coils (HydroCoil): early single-center experienceA Berenstein, J K Song, Y Niimi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2012
Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancerM A Socinski, C J Langer, I Okamoto, et al.
The Laryngoscope|September 2, 2006
Laryngeal cancer in the United States: changes in demographics, patterns of care, and survivalHenry T Hoffman, Kimberly Porter, Lucy H Karnell, et al.
Mbio|May 25, 2017
Mutations That Alter the Bacterial Cell Envelope Increase Lipid ProductionKimberly C Lemmer, Weiping Zhang, Samantha J Langer, et al.
Journal of Neurological Surgery. Part A, Central European Neurosurgery|December 8, 2020
Brain Arteriovenous Malformations: Impact of Neurologic Status, Bleeding, and Type of Treatment on Final OutcomeSara García-Duque, Roberto García-Leal, Begoña Iza-Vallejo, et al.
Pageof 60